Earlier this month, Novo Nordisk said it expects continued competition from copycat version Wegovy this year and rising pressure from main U.S. rival, Eli Lilly
Read More Novo Nordisk to offer Ozempic at $499 per month to eligible US customersTag: Novo Nordisk
Trump sends 17 pharmaceutical companies letters calling for them to commit to lowering U.S. prescription drug prices
President Donald Trump sent letters to the CEOs of 17 major pharmaceutical companies, including Pfizer, Johnson & Johnson, AstraZeneca, Eli Lilly, and more – with the letters calling for the companies to commit to lowering U.S. prescription drug prices within 60 days, setting a deadline of September 29th.
Read More Trump sends 17 pharmaceutical companies letters calling for them to commit to lowering U.S. prescription drug pricesFat, not muscle: drugmakers in race for next weight-loss breakthrough
Current weight-loss methods and popular therapies like Wegovy and Zepbound result in both fat and muscle loss, which could be especially harmful for older patients.
Read More Fat, not muscle: drugmakers in race for next weight-loss breakthroughOzempic copies restricted after US judge denies injunction
A U.S. judge rejected a bid by compounding pharmacies to keep making copies of Novo Nordisk’s popular drugs Ozempic and Wegovy while a legal challenge over drug shortages unfolds.
Read More Ozempic copies restricted after US judge denies injunction15 Additional Drugs Chosen For Medicare Negotiation
The Centers for Medicare and Medicaid Services (CMS) has picked 15 more drugs for Medicare price negotiation.
Read More 15 Additional Drugs Chosen For Medicare NegotiationBernie Sanders Demands Novo Nordisk CEO Lower Weight Loss Drug Prices For Americans
During a Senate committee hearing on Tuesday, lawmakers questioned the manufacturer of popular weight loss drugs like Ozempic and Wegovy, citing what Senator Bernie Sanders called “outrageously high” drug prices.
Read More Bernie Sanders Demands Novo Nordisk CEO Lower Weight Loss Drug Prices For Americans